Key insights
- Everspin Technologies (MRAM) secured a significant defense contract and manufacturing agreement, driving a stock rally. Q1 results were positive, but valuation metrics are stretched with a high P/E and analyst price targets suggesting downside. Overbought RSI and insider selling raise concerns about sustainability, suggesting a bearish short-term outlook for the stock and potentially dampening sentiment in related defense tech.
I kept seeing MRAM mentioned after it went from 13.81 to 37.57 in 15 trading days, and decided to actually sit down and look at the fundamentals rather than just the chart. Here is what I found.
The move was not random or purely retail-driven. Everspin Technologies announced a 40 million dollar subcontract with a U.S. defense prime contractor on April 30 to supply Toggle MRAM technology for Defense Industrial Base programs. The contract runs 2.5 years. Their total trailing twelve-month revenue is 55.2 million dollars. That one contract alone is worth more than 70 percent of annual revenue locked into backlog.
Alongside that, they separately announced a 10-year manufacturing agreement with Microchip Technology to expand U.S.-based MRAM production capacity. The defense procurement trend heavily favors domestically sourced components right now, and that deal makes Everspin a more eligible supplier for future programs before those programs even go to bid.
Q1 2026 results backed the narrative too. Revenue was 14.87 million versus 13.14 million a year earlier, the net loss narrowed to just 296,000 dollars, and gross margin hit 52.7 percent. Q2 guidance calls for 15.5 to 16.5 million in revenue.
Now, the part that keeps me from piling in at current levels.
The stock has a trailing P/E of 3,757 times because earnings are essentially zero on a GAAP basis. The forward P/E is 80.8 times. The two analysts who cover it have a mean price target of 18.00 dollars, which implies 52 percent downside from 37.57. Fair value models come in around 17 dollars.
The RSI is at 73.9, which is overbought, and the recent rally has not been backed by consistently expanding volume. Volume dropped from 15.7 million shares on May 13 to 4.4 million by May 15 as the price held up.
Insider activity also caught my attention. Over the last three months, there were nine open-market sales averaging 27.91 USD per share and zero open-market purchases. That does not sink the thesis but it is worth knowing.
The technology itself is genuinely interesting. Everspin is the only company commercially shipping MRAM at scale. Toggle MRAM is radiation-tolerant, non-volatile, and operates across a wide temperature range. For defense applications, those are not nice-to-have features. They are requirements that eliminate most alternatives. Once a defense program designs this into a platform, the switching cost to change memory suppliers is enormous.
The balance sheet is fine. 44.45 million in cash, 3.34 million in debt, current ratio of 4.84. Altman Z-Score of 9.54 puts it in safe territory. Operating cash flow over the trailing twelve months was 9.96 million dollars.
My opinion: The valuation at current prices has already priced in a lot of the good news and then some. The technically cleaner entry would be a pullback toward the 20-day moving average around $27.46, or a confirmed breakout above 45.54 on heavy volume.